Ring Therapeutics

Ring Therapeutics

Latest funding
$117,000,000
Venture capital (Series B) - 2021
T. Rowe Price Invus Partners Investment +3
Team Size
1–10
Employees
$117,000,000 Venture capital (Series B)
MedCity News

Ring Therapeutics rounds up $117M to find better viral vectors for gene therapy

Xconomy

Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options